MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Substantia nigra"

  • 2023 International Congress

    Preliminary Report on Neuromelanin-Sensitive MRI Signal change after Allogeneic Bone marrow-derived Mesenchymal Stem Cells therapy: Phase IIa double-blind, randomized controlled trial

    J. Suescun, M. Schiess, E. Rodarte, C. Adams, T. Ellmore (Houston, USA)

    Objective: To select the most effective number of repeat doses of mesenchymal stem cells (MSC) delivered intravenously to slow the progression of Parkinson’s disease (PD).…
  • 2023 International Congress

    Are GDNF receptors the gatekeepers of GDNF efficacy during progressive nigrostriatal neuron loss?

    M. Salvatore, E. Kasanga, Y. Han, R. Mcmanus, W. Navarrete, V. Nejtek, J. Richardson (Fort Worth, USA)

    Objective: To determine if GDNF receptor expression levels in the striatum or substantia nigra (SN) change in relation to differences in tyrosine hydroxylase (TH) and…
  • 2022 International Congress

    MPTP-induced structural reorganization of neurons in mice Basal Ganglia: Verifying the sequelae of differential toxicity

    B. Bhaduri, I. Datta, R. Yadav, D. Srinivas, P. Alladi (Bangalore, India)

    Objective: To evaluate the changes in the neuronal arborization of the medium spiny neurons of striatum & substantia nigra neurons,  in response to MPTP in…
  • 2022 International Congress

    Single-cell characterization of patient midbrain tissue reveals tissue remodeling and glial activation in Parkinson’s disease

    S. Smajic, C. Prada-Medina, Z. Landoulsi, J. Ghelfi, S. Delcambre, C. Dietrich, J. Jarazo, J. Henck, S. Balachandran, S. Pachchek, C. Morris, P. Anotny, B. Timmermann, S. Sauer, S. Pereira, J. Schwamborn, P. May, M. Spielmann (Esch-sur-Alzette, Luxembourg)

    Objective: We aim to characterize the contribution of each midbrain cell type to PD pathology, and to identify cell types associated with genetic PD-risk variants.…
  • 2022 International Congress

    Fibrinogen and CFAH: The two putative markers of Parkinson’s disease with cognitive impairment

    A. Naskar, S. M, S. Sengupta, P. Pal, P. Alladi (Bengaluru, India)

    Objective: To determine the pathogenic potential of fibrinogen and complement factor H (CFAH) in causing Parkinson’s disease (PD) with cognitive impairment (PDCI)-like symptoms using C57BL/6J…
  • 2022 International Congress

    Quantity detection of Substantia nigra hyperechogenicity based on digital image analysis for diagnosing Parkinson’s disease

    L. Gao, Z. Xue, X. Zhou (Nanchang, China)

    Objective: We aimed to apply digital analysis to quantify hyperechogenicity of Substantia nigra, and explore its clinical value for the diagnosis of PD. Background: Increased…
  • 2022 International Congress

    Multimodal MRI assessment of the substantia nigra in premotor and motor stages of parkinsonism

    J. Pasquini, MJ. Firbank, L. Best, V. Foster, V. Silani, G. Petrides, DJ. Brooks, KN. Anderson, N. Pavese (Newcastle upon Tyne, United Kingdom)

    Objective: To investigate substantia nigra (SN) MRI abnormalities through Neuromelanin (NM) and diffusion MRI (dMRI) with Neurite Orientation Dispersion and Density Index (NODDI) in the…
  • 2022 International Congress

    Smoking and Substantia Nigra Neuron Density in the Presence and Absence of Lewy Pathology

    G. Ross, R. Abbott, H. Petrovitch, J. Duda, J. Uyehara-Lock, K. Masaki, C. Tanner (Honolulu, USA)

    Objective: Our objective is to examine the association of mid-life smoking with post mortem substantia nigra (SN) neuron density in the presence and absence of…
  • 2022 International Congress

    Neuropathological profile of tauopathy in spinocerebellar ataxia type 8

    G. Beck, Y. Yonenobu, R. Yamashita, T. Iwaki, S. Murayama, H. Mochizuki (Suita, Japan)

    Objective: The purpose of this study is to examine the distribution of tau pathology in brain regions of patients with spinocerebellar ataxia type 8 (SCA8).…
  • 2022 International Congress

    Visual Hallucinations and Parkinson’s Disease Neuropathology among Decedents with and without Parkinson’s Disease or Lewy Body Dementia During Life

    H. Petrovitch, R. Abbott, M. Barrett, K. Masaki, C. Tanner, J. Uyehara-Lock, W. Ross (Honolulu, USA)

    Objective: The purpose of this report is to examine the association between visual hallucinations during life and substantia nigra (SN) neuron density and Lewy pathology…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley